aibioNYSE American files to remove Calidi Biotherapeutics warrants from listing
Tickers CLDI
The notice, dated October 28, 2024, covers the company's redeemable warrants with a $115.00 exercise price, not its common stock.
Key facts
- Company
- Calidi Biotherapeutics, Inc. (AMEX: CLDI)
- News type
- Listings
- Primary source
- Calidi Biotherapeutics, Inc. 25-NSE (2024-10-28)
NYSE American LLC has filed a notice with the Securities and Exchange Commission to remove the redeemable warrants of Calidi Biotherapeutics, Inc. from listing and registration. The notice is dated October 28, 2024.
The notice covers only the warrants. A warrant gives its holder the right to buy shares at a set price. According to the filing, each whole Calidi warrant is exercisable for one tenth of a share of common stock at an exercise price of $115.00.
The exchange filed the notice under 17 CFR 240.12d2-2(b), the SEC rule that covers removals started by an exchange rather than by the company. The common stock is not named in the notice. The form lists the company's address at 11110 Sunset Hills Road in Reston, Virginia, and its commission file number as 001-40789.